Key Players:Agilent Technologies, AstraZeneca, AmbioPharm - A Global Peptide CDMO, Bachem, Biosynth, Corden Pharma - A Full-Service CDMO, CSBio, ChinaPeptides Co., Ltd., Eli Lilly and Company, GenScript, GSK, Merck Group, Novo Nordisk, PolyPeptide Group, Sanofi, ScinoPharm Taiwan Ltd, Thermo Fisher Scientific, TakedaPharmaceutical Nordics AB, Teva Pharmaceuticals, amo ng others
They stepped up over months
Development of subtype-selective oestrogen receptor-based therapeutics
One online pharmacy asks customers to fill out a questionnaire and then send a photo of them standing on a scale - to prove their weight - along with photos showing their body
Among participants with full adherence, the weight loss reached 22.7%, with 40.4% losing more than 25% of their body weight and over 50% reducing their BMI below the obesity threshold
Hence, it is discouraged to use it purely for cosmetic or aesthetic purposes as it can cause harm if used without supervision and close monitoring of symptoms